近期新股的首日表现渐趋疲软,连今年大火的创新药概念似乎也有点顶不住了。12月22日,港股市场迎来四只新股上市,均在首日遭遇下跌。其中,华芢生物-B(02396.HK)走势相对较强,截至发稿时间下挫约6.65%,股价现为35.66港元,而发行价为38.2港元,已经破发。而在此之前,近两三个月上市的创新药概念新股,如宝济药业-B(02659.HK)、旺山旺水-B(02630.HK)、轩竹生物-B(...
Source Link近期新股的首日表现渐趋疲软,连今年大火的创新药概念似乎也有点顶不住了。12月22日,港股市场迎来四只新股上市,均在首日遭遇下跌。其中,华芢生物-B(02396.HK)走势相对较强,截至发稿时间下挫约6.65%,股价现为35.66港元,而发行价为38.2港元,已经破发。而在此之前,近两三个月上市的创新药概念新股,如宝济药业-B(02659.HK)、旺山旺水-B(02630.HK)、轩竹生物-B(...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.